Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Targeting GABA-transported GAT-3 in astrocytes reduces negative outcomes of brain injury

July 19, 2022

Amylyx sponsors research at SRI on Bax and Bak inhibitors for ALS and neurodegenerative diseases

July 19, 2022

Merck & Co. synthesizes orexin OX2 receptor agonists

July 18, 2022

Novartis divulges new cGAS inhibitors

July 18, 2022

GlaxoSmithKline synthesizes new Nav1.8 channel blockers

July 15, 2022

Pandeia Therapeutics patents new GPR88 agonists

July 15, 2022

UCB SA patents DRD1 PAMs

July 14, 2022

"Master sites" trigger cascade of tau phosphorylation in Alzheimer's disease

July 13, 2022

MJFF grant supports evaluation of EpicentRx's NLRP3 inflammasome inhibitor for Parkinson's

July 13, 2022

UCB SA divulges new DRD1 PAMs

July 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...